OVR115 Antibody Compositions and Methods of Use
AssigneediaDexus, Inc.
InventorJackie Papkoff
Life of this patent
Estimating the term…
Abstract
The invention encompasses a method of inhibiting growth of tumor cells in vivo, comprising contacting the cells with an anti-Ovr1 15 antibody, or antigen binding fragment thereof. This invention also encompasses a method of alleviating an Ovr1 15-expressing cancer in a mammal, comprising administering a therapeutically effective amount of an anti-Ovr1 15 antibody, or antigen binding fragment thereof, to the mammal.
Claims36
A method for inhibiting growth of tumor cells in vivo, comprising contacting the cells with an anti-Ovr115 antibody, or antigen binding fragment thereof, in an amount effective to inhibit growth of the tumor cells.
(canceled)
6-9. (canceled)
(canceled)
A method of inhibiting tumor growth in a mammal comprising administering a therapeutically effective amount of an anti-Ovr115 antibody, or antigen binding fragment thereof, to the mammal.
(canceled)
21-24. (canceled)
(canceled)
A method of alleviating an Ovr115-expressing cancer in a mammal and/or increasing survival of a mammal with an Ovr115-expressing cancer, comprising administering a therapeutically effective amount of an anti-Ovr115 antibody, or antigen binding fragment thereof, to the mammal.
The method of claim 0, wherein the antibody, or antigen binding fragment thereof, is selected from the group consisting of Ovr115.F64.2.7 and Ovr115.F76.2.3.
(canceled)
36-39. (canceled)
(canceled)
45-58. (canceled)
Dependencies are inferred from the claim text.